ACS & ASCO are Stronger Together: Cancer.Net content is now available on cancer.org.
Cancer news from the American Cancer Society.
Published on: June 13, 2024
A recent study shows that giving immunotherapy before surgery for stage III melanoma can help stop the spread of the disease and cut time spent in treatment.
Published on: June 13, 2024
A study shows that a targeted therapy drug stops the spread of lung cancer for 5 years or more. The drug, lorlatinib (Lobrena), also stops new cancer growth in the brain.
Published on: June 13, 2024
A study has shown that giving patients with lung cancer a targeted therapy drug after combined chemotherapy and radiation therapy helps them live longer without the cancer growing or spreading.
Published on: June 1, 2023
Follow research highlighted each day in this ongoing meeting by checking out the ASCO News Highlights for People with Cancer blog.
Published on: June 18, 2020
The US Food and Drug Administration (FDA) has expanded the approval of the immunotherapy drug pembrolizumab (Keytruda) to include any cancer with a high tumor mutational burden (TMB-H).